172@29@17@151!~!172@29@0@53!~!|news|tags|2017-outlook.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
you are here: HomeNews2017 outlook
2017 outlook
Jump to
2 Results Found
  • Expect contrasting fortunes in 2017; H1 more challenging than H2 Jan 02, 2017 04:48 PM IST

    Expect contrasting fortunes in 2017; H1 more challenging than H2

    We believe 2017 is going to be a year of contrasting performance with the first half being more challenging, driven by domestic and global events and the second half seeing a sharp recovery.

  • 5 trends to watch out for in the pharma sector in 2017 Dec 30, 2016 07:07 PM IST

    5 trends to watch out for in the pharma sector in 2017

    From the look of it 2017 is unlikely to be any easier. Pricing pressures in US– the world‘s largest market for generic drugs—tighter regulatory scrutiny by the US FDA and thereby higher compliance costs, global macro-economic uncertainty and price controls back home are expected to continue in the 2017.

Sections